Delivery Order SPE2DB25D3008-SPE2DB25FRCCZ
Award Date
5/22/25
Potential Completion Date
6/13/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,833,079 units of PROQUAD vaccine vials. The $3,203.98 firm fixed price contract has an ultimate completion date of October 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical for the comprehensive supply of pharmaceutical and medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,772,992 PROQUAD vaccine vials. The fixed-price contract has a ceiling value of $1,570.54 and an ultimate completion date of October 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,821,936 doses of the PROQUAD vaccine. The $11,187.81 firm-fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA, valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,141.08 to Amerisourcebergen Drug Corporation's Corporate Office division to provide 4,564,608,705 doses of the PROQUAD vaccine. The contract has an ultimate completion date of June 3, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
The U.S. Department of Defense (DoD) has awarded a $3,203.98 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,520,288 doses of the PROQUAD vaccine. The award does not have a set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,124,933 units of PROQUAD VIALS. The $1,687.48 contract has a completion date of May 19, 2025 and was awarded on April 28, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,376,885 units of the PROQUAD vaccine. The contract has a ceiling value of $4,159.95 and is a Firm Fixed Price arrangement with a period of performance through November 29, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a broader $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4,563,759,819 doses of the PROQUAD vaccine, with a potential value of $7,673.88 and a completion date of March 13, 2024. The award was made on February 21, 2024, and there was no set-aside designation used....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of 4566782414 PROQUAD VIALS, a type of vaccine, with a ceiling value of $3,312.64. The contract has a firm fixed price pricing type and an ultimate completion date of January 13, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD vaccine vials. The contract has a ceiling value of $6,407.96 and a completion date of May 31, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....